COVID guidelines

COVID-19 guidance for managing parathyroid conditions
Coronavirus and parathyroid conditions FAQs 
Written by Parathyroid UK with help from our medical advisors

Template letter for doctors to give to patients with hypoparathyroidism
Produced by the Society for Endocrinology 

COVID-19 Guidance for management of hypoparathyroidism and primary hyperparathyroidism
Endocrinology in the time of Covid-19: Management of calcium metabolic disorders and osteoporosis 
EJE bioscientifica, Gittoes et al, May 2020

Hypopara Guidelines

European Society for Endocrinology(ESE) Clinical Guideline:Treatment of Chronic Hypoparathyroidism in Adults
Bollerslev et al, EJE 173:2 July 2015

BAETS Post Thyroidectomy Hypocalcaemia Guidelines
Data from the UK Registry of Endocrine and Thyroid Surgery (www.baets.org.uk/audit) shows that post thyroidectomy hypocalcaemia rates can reach 27%. Read more here and see  BAETS Post op hypopcalcaemia management guidance here 

Hyperpara Guidelines

NICE guidelines on Primary Hyperparathyroidism
Nice guideline (NG132) 23rd May 2019
Parathyroid UK helped to develop this guideline which covers diagnosing, assessing and managing primary hyperparathyroidism. It aims to improve recognition and treatment of this condition, reducing long‑term complications and improving quality of life.